Snapshot of the pharmaceutical promotional literature of Bangladesh: A critical review
Abstract
The present research was conducted to evaluate the quality of pharmaceutical promotional literature. Indications was mentioned in 88.2% promotional literature and less than half (40.0, 33.9 and 38.9%) of these contains side effects, precautions and contraindications respectively. Among the provided information 67.3%, 16.5%, 19.5% and 24.0% matched with the BDNF/BNF respectively. Scientific articles (73.3%) were cited most followed by commercial online sources (15.5%), data on file (4.2%), regulatory body approval data (2.9%), product monograph (2.7%) and textbook/reference book (1.6%). Only half (50.2%) of these cited references were retrievable and no ‘data on file’ could be retrieved. Though most (73.2%) of the promotional claims were true, 13.7, 5.9, 4.6 and 2.6% were identified as false, exaggerated, ambiguous and controversial respectively. This revelation about the quality of promotional literature might an eye opener for the policy makers. More importantly, this may bring alertness among the physicians during interpretation of pharmaceutical promotion literature.
Downloads
1214
840 Read
378
References
Alam K, Shah AK, Ojha P, Palaian S, Shankar PR. Evaluation of drug promotional materials in a hospital setting in Nepal. Southern Med Rev. 2009; 2: 2-6.
Alssageer MA, Kowalski SR. A survey of pharmaceutical company representative interactions with doctors in Libya. Libyan J Med. 2012; 2012.
Alssageer MA, Kowalski SR. Doctors’ opinions of information provided by Libyan pharmaceutical company representatives. Libyan J Med. 2012; 2012.
Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982; 73: 4-8.
Begum M, Rahman MS, Islam AFMS, Khan IA, Akhter N. Eleven years of the undergraduate medical curriculum 1988: Review on the changes in pharmacology written questions. Bangladesh J Physiol Pharmacol. 1999; 15: 27-30.
Daher M. Ethical issues in the geriatric patient with advanced cancer ‘living to the end’. Ann Oncol. 2013; 24: 55-58.
Directorate General of Drug Administration (DGDA). Code of pharmaceutical marketing practices. Directorate general of drug administration. Dhaka, 1994.
Greene JA, Podolsky SH. Keeping modern in medicine: Pharmaceutical promotion and physician education in postwar America. Bull Hist Med. 2009; 83: 331-77.
Haque N, Haque M, Sultana R, Kawsar S, Islam MZ. Teaching medical students the skills required to critically evaluate the drug information sources for rational prescribing-report of an exercise on evaluation of prescribing information. Bangladesh J Physiol Pharmacol. 2005; 21: 1-4.
Ijoma U, Onwuekwe I, Onodugo O, Agawa E, Ejim E, Onydum C, Onah E, Okwudire E, Ogwuonah G. Effect of promotional strategies of pharmaceutical companies on doctor’s prescription pattern in South-East Nigeria. TAF Prev Med Bull. 2010; 9: 1-6.
Islam MS, Farah SS. Misleading promotion of drugs in Bangladesh: Evidence from drug promotional brochures distributed to general practitioners by the pharmaceutical companies. J Pub Health. 2007; 29: 212-13.
Jadav SS, Dumatar CB, Dikshit RK. Drug promotional literatures (DPLs) evaluation as per World Health Organization (WHO) criteria. J Appl Pharmaceut Sci. 2014; 4: 84-88.
Jaykaran DS, Saxena D, Yadav P, Kantharia ND. Drug promotional literature distributed by pharmaceutical companies: Do they provide enough information to ascertain their validity? J Pharmacol Pharmacother. 2011; 2: 192-94.
Khakhkhar T, Mehta M, Shah R, Sharma D. Evaluation of drug promotional literatures using WHO guidelines. J Pharma Neg Res. 2013; 4: 33-38.
Mali SN, Dudhgaonkar S, Bachewar NP. Evaluation of rationality of promotional drug literature using World Health Organization guidelines. Ind J Pharmacol. 2010; 42: 267-72.
May CD. Selling drugs by ‘educating’ physicians. J Med Educat. 1961; 36: 1-23.
Mikhael EM. Evaluating the reliability and accuracy of the promotional brochures from the generic pharmaceutical companies in Iraq using World Health Organization guidelines. J Pharma Bioallied Sci. 2015; 7: 65-68.
Murthy MB, Krishnamurthy B. Authenticity of claims made in drug promotional literature. Ind J Pharmacol. 2010; 42: 59-60.
Norris P, Herxheimer A, Lexchin J. Drug promotion: What we know, what we have yet to learn. World Health Organization/Health Action International, Geneva, Switzerland, 2005.
Othman N, Vitry A, Roughhead EE. Quality of Pharmaceutical Advertisements in Medical Journals: A Systemic review. PLoS One. 2009; 4: 7, e 6350.
Rahman MS, Begum M, Haque MZ, Akhter N. Drug advertisement in medical journals. Bangladesh J Physiol Pharmacol. 1999; 15: 31-36.
Rahman MS. Changes required in pharmacotherapy teaching to ensure rational use of drugs (letter to the editor). Bangladesh J Physiol Pharmacol. 1995; 11: 38-39.
Rahman MS. New global situation in drug regulation: Redefine responsibility of the pharmacologists of Bangladesh. Bangladesh J Physiol Pharmacol. 1999; 15: 41-42.
Randhawa GK, Singh NR, Rai J, Kaur G, Kashyap R. A critical analysis of claims and their authenticity in Indian drug promotional advertisements. Advan Med. 2015; 2015.
Rohra DK, Gilani AH, Memon TK, Perven G, Khan MT, Zafar H. Critical evaluation of claims made by pharmaceutical companies in drug promotional material in Pakistan. J Pharmacol Pharmaceut Sci. 2006; 9: 50-59.
Saibhavana D, Mukta CN, Nithyananda CK. Critical evaluation of drug promotional literature for drug used in cardiovascular diseases. Int J Pharma Pharmaceut Sci. 2015; 7: 405-07.
Copyright (c) 2018 Fatema Johora, Md. Sayedur Rahman
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
